| Trial of sodium phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis S Paganoni, EA Macklin, S Hendrix, JD Berry, MA Elliott, S Maiser, ... New England Journal of Medicine 383 (10), 919-930, 2020 | 413 | 2020 |
| Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis S Paganoni, S Hendrix, SP Dickson, N Knowlton, EA Macklin, JD Berry, ... Muscle & nerve 63 (1), 31-39, 2021 | 165 | 2021 |
| A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression MD Weiss, EA Macklin, Z Simmons, AS Knox, DJ Greenblatt, N Atassi, ... Neurology 86 (16), 1474-1481, 2016 | 98 | 2016 |
| Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies E Burnor, L Yang, H Zhou, KR Patterson, C Quinn, MM Reilly, AM Rossor, ... Neurology 90 (1), e31-e38, 2018 | 87 | 2018 |
| Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing TI Jones, C Yan, PC Sapp, D McKenna-Yasek, PB Kang, C Quinn, ... Clinical epigenetics 6, 1-16, 2014 | 83 | 2014 |
| Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double … B Schoser, M Roberts, BJ Byrne, S Sitaraman, H Jiang, P Laforêt, ... The Lancet Neurology 20 (12), 1027-1037, 2021 | 65 | 2021 |
| Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5-year outcomes of the SURTAVI randomized clinical trial NM Van Mieghem, GM Deeb, L Søndergaard, E Grube, S Windecker, ... JAMA cardiology 7 (10), 1000-1008, 2022 | 62 | 2022 |
| Development and validation of the Rasch-Built overall amyotrophic lateral sclerosis disability scale (roads) CN Fournier, R Bedlack, C Quinn, J Russell, D Beckwith, KH Kaminski, ... JAMA neurology 77 (4), 480-488, 2020 | 60 | 2020 |
| Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR … S Paganoni, S Hendrix, SP Dickson, N Knowlton, JD Berry, MA Elliott, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (8), 871-875, 2022 | 54 | 2022 |
| Adaptive platform trials to transform amyotrophic lateral sclerosis therapy development S Paganoni, JD Berry, M Quintana, E Macklin, BR Saville, MA Detry, ... Annals of neurology 91 (2), 165-175, 2022 | 52 | 2022 |
| Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis C Quinn, C Edmundson, N Dahodwala, L Elman Muscle & nerve 61 (4), 508-511, 2020 | 50 | 2020 |
| Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS C Quinn, L Elman, L McCluskey, K Hoskins, C Karam, JH Woo, H Poptani, ... Neurology 79 (6), 583-588, 2012 | 47 | 2012 |
| An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis CN Fournier, D Schoenfeld, JD Berry, ME Cudkowicz, J Chan, C Quinn, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19 (3-4), 242-249, 2018 | 42 | 2018 |
| Alexia due to ischemic stroke of the visual word form area PE Turkeltaub, EM Goldberg, WA Postman-Caucheteux, M Palovcak, ... Neurocase 20 (2), 230-235, 2014 | 39 | 2014 |
| Amyotrophic lateral sclerosis and other motor neuron diseases C Quinn, L Elman CONTINUUM: Lifelong Learning in Neurology 26 (5), 1323-1347, 2020 | 34 | 2020 |
| Necrotizing myopathies: an update C Quinn, JS Salameh, T Smith, N Souayah Journal of clinical neuromuscular disease 16 (3), 131-140, 2015 | 33 | 2015 |
| Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis S Corrochano, R Männikkö, PI Joyce, P McGoldrick, J Wettstein, G Lassi, ... Brain 137 (12), 3171-3185, 2014 | 30 | 2014 |
| Genotype–phenotype correlations in valosin-containing protein disease: a retrospective muticentre study M Schiava, C Ikenaga, RN Villar-Quiles, M Caballero-Ávila, A Topf, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (10), 1099-1111, 2022 | 23 | 2022 |
| Genetic test utilization and diagnostic yield in adult patients with neurological disorders TM Bardakjian, I Helbig, C Quinn, LB Elman, LF McCluskey, SS Scherer, ... Neurogenetics 19, 105-110, 2018 | 22 | 2018 |
| The reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) among dermatologists, rheumatologists and neurologists J Tiao, R Feng, S Bird, JK Choi, J Dunham, M George, ... British Journal of Dermatology 176 (2), 423-430, 2017 | 21 | 2017 |
